183 related articles for article (PubMed ID: 9793832)
61. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
[TBL] [Abstract][Full Text] [Related]
62. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
[TBL] [Abstract][Full Text] [Related]
63. Screening for prostate cancer.
Waldman AR; Osborne DM
Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
[TBL] [Abstract][Full Text] [Related]
64. Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.
Guerra CE; Gimotty PA; Shea JA; Pagán JA; Schwartz JS; Armstrong K
Med Decis Making; 2008; 28(5):681-9. PubMed ID: 18556635
[TBL] [Abstract][Full Text] [Related]
65. Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study.
Scherer TP; Saba K; Wettstein MS; Lucca I; Mortezavi A; Waisbrod S; Aujesky D; Capaul R; Strebel RT
Swiss Med Wkly; 2023 Sep; 153():40115. PubMed ID: 37774392
[TBL] [Abstract][Full Text] [Related]
66. Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.
Schwartz MJ; Hwang DH; Hung AJ; Han J; McClain JW; Shemtov MM; Te AE; Sosa RE; Vaughan ED; Scherr DS
Cancer; 2008 Apr; 112(8):1718-25. PubMed ID: 18330908
[TBL] [Abstract][Full Text] [Related]
67. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
Cao XL; Gao JP; Han G; Tang J; Hong BF
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
[TBL] [Abstract][Full Text] [Related]
68. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
[TBL] [Abstract][Full Text] [Related]
69. Identifying Primary Care Physicians Continuing Education Needs by Examining Clinical Practices, Attitudes, and Barriers to Screening Across Multiple Cancers.
Lynn B; Hatry A; Burnett C; Kan L; Olatunbosun T; Bluman B
J Cancer Educ; 2018 Dec; 33(6):1255-1262. PubMed ID: 28643286
[TBL] [Abstract][Full Text] [Related]
70. What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening?
Haider MR; Qureshi ZP; Horner R; Friedman DB; Bennett C
Clin Genitourin Cancer; 2017 Dec; 15(6):e977-e985. PubMed ID: 28625690
[TBL] [Abstract][Full Text] [Related]
71. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record.
Aminsharifi A; Schulman A; Anderson J; Fish L; Oeffinger K; Shah K; Sze C; Tay KJ; Tsivian E; Polascik TJ
Urol Oncol; 2018 Nov; 36(11):502.e1-502.e6. PubMed ID: 30170982
[TBL] [Abstract][Full Text] [Related]
72. Establishing the need for family medicine training in intimate partner violence screening.
Pagels P; Kindratt TB; Reyna G; Lam K; Silver M; Gimpel NE
J Community Health; 2015 Jun; 40(3):508-14. PubMed ID: 25352415
[TBL] [Abstract][Full Text] [Related]
73. Emergency contraception provision: a survey of Michigan physicians from five medical specialties.
Xu X; Vahratian A; Patel DA; McRee AL; Ransom SB
J Womens Health (Larchmt); 2007 May; 16(4):489-98. PubMed ID: 17521252
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
[TBL] [Abstract][Full Text] [Related]
75. The practice of pediatric sleep medicine: results of a community survey.
Owens JA
Pediatrics; 2001 Sep; 108(3):E51. PubMed ID: 11533369
[TBL] [Abstract][Full Text] [Related]
76. Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based survey.
Kim HL; Benson DA; Stern SD; Gerber GS
Urology; 2002 Feb; 59(2):266-71. PubMed ID: 11834400
[TBL] [Abstract][Full Text] [Related]
77. Why do men refuse or attend population-based screening for prostate cancer?
Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
[TBL] [Abstract][Full Text] [Related]
78. Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).
Kranse R; Beemsterboer P; Rietbergen J; Habbema D; Hugosson J; Schröder FH
Prostate; 1999 Jun; 39(4):316-22. PubMed ID: 10344223
[TBL] [Abstract][Full Text] [Related]
79. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
[TBL] [Abstract][Full Text] [Related]
80. Discussions about prostate cancer screening between U.S. primary care physicians and their patients.
Hall IJ; Taylor YJ; Ross LE; Richardson LC; Richards TB; Rim SH
J Gen Intern Med; 2011 Oct; 26(10):1098-104. PubMed ID: 21416405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
